Key Points
- Intuitive Surgical EVP Mark Brosius sold 77 shares at an average price of $375.57, generating $28,918.89. The sale was made under a pre-arranged Rule 10b5-1 plan, leaving him with 881 shares.
- ISRG shares opened at $378.81, while the company’s latest quarterly results exceeded expectations: adjusted EPS was $2.80 versus the $2.48 consensus, and revenue rose 18.4% year over year to $2.89 billion.
- Analysts maintain a broadly positive view, with a consensus “Moderate Buy” rating and an average price target of $508.68, although several firms recently lowered their targets amid concerns about slower growth and valuation.
Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Mark Brosius sold 77 shares of the company's stock in a transaction on Friday, August 21st. The stock was sold at an average price of $375.57, for a total value of $28,918.89. Following the completion of the sale, the executive vice president owned 881 shares of the company's stock, valued at $330,877.17. This represents a 8.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Mark Brosius also recently made the following trade(s):
- On Wednesday, August 19th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The shares were sold at an average price of $394.26, for a total value of $30,358.02.
- On Monday, August 17th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The shares were sold at an average price of $390.67, for a total transaction of $30,081.59.
- On Friday, July 31st, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $351.00, for a total value of $9,828.00.
- On Wednesday, July 29th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The stock was sold at an average price of $360.21, for a total transaction of $10,085.88.
- On Monday, July 27th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $344.00, for a total transaction of $9,632.00.
- On Friday, June 12th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The stock was sold at an average price of $414.13, for a total value of $10,353.25.
- On Wednesday, June 10th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The stock was sold at an average price of $424.14, for a total transaction of $9,755.22.
- On Monday, June 8th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The shares were sold at an average price of $420.12, for a total value of $9,662.76.
Intuitive Surgical Stock Up 1.2%
ISRG stock opened at $378.81 on Friday. The firm has a market cap of $133.83 billion, a P/E ratio of 43.39, a PEG ratio of 2.71 and a beta of 1.46. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The company's 50-day simple moving average is $388.47 and its 200-day simple moving average is $436.69.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.48 by $0.32. The business had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company's revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter last year, the business earned $1.81 earnings per share. On average, analysts anticipate that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.
Institutional Trading of Intuitive Surgical
A number of large investors have recently modified their holdings of the stock. Deutsche Bank AG grew its holdings in shares of Intuitive Surgical by 9.6% during the fourth quarter. Deutsche Bank AG now owns 1,522,191 shares of the medical equipment provider's stock worth $862,108,000 after purchasing an additional 132,966 shares during the last quarter. Oppenheimer Asset Management Inc. increased its holdings in shares of Intuitive Surgical by 29.3% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 71,077 shares of the medical equipment provider's stock valued at $40,255,000 after acquiring an additional 16,119 shares during the period. Jag Capital Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at $18,771,000. Sycomore Asset Management purchased a new stake in Intuitive Surgical in the 4th quarter valued at $10,730,000. Finally, Plato Investment Management Ltd acquired a new stake in Intuitive Surgical during the 2nd quarter worth $4,315,000. Hedge funds and other institutional investors own 83.64% of the company's stock.
Trending Headlines about Intuitive Surgical
Here are the key news stories impacting Intuitive Surgical this week:
- Positive Sentiment: Operating margin is widening. Intuitive Surgical’s operating margin has expanded in each of the past three years, suggesting improving efficiency and earnings quality even as U.S. procedure growth moderates. Intuitive Surgical Stock Has Fallen While Its Operating Margin Keeps Widening
- Positive Sentiment: Wall Street remains broadly constructive. Analysts generally view ISRG favorably, with a consensus “Moderate Buy” rating and price targets substantially above recent trading levels. Recent upgrades and bullish commentary point to confidence in the da Vinci platform’s long-term growth. Is Wall Street Bullish or Bearish on Intuitive Surgical Stock?
- Positive Sentiment: Asia-Pacific capacity is expanding. A new manufacturing plant in Penang, Malaysia, is intended to increase regional capacity and support demand for robotic-assisted surgery, strengthening ISRG’s international growth opportunity. Intuitive Surgical Expands Manufacturing Footprint in Asia Pacific
- Neutral Sentiment: The company faces an execution test. Investors are weighing whether Intuitive can sustain system placements, procedure growth and recurring instrument revenue while expanding internationally and navigating a more cautious healthcare spending environment. Why Is Intuitive Surgical Facing an Execution Test?
- Negative Sentiment: Growth and valuation remain concerns. Investors continue to digest management’s cautious procedure-growth outlook of roughly 13.5%–15.5% for 2026, along with an estimated tariff impact on gross margin. With ISRG trading well below its prior high but still at a premium earnings multiple, valuation compression may continue if growth slows further. Intuitive Surgical Slides as Investors Digest Cautious Outlook
- Negative Sentiment: Insider selling adds a modest overhang. An executive vice president sold a small position under a pre-arranged Rule 10b5-1 plan. The transaction is not necessarily a fundamental warning, but broader recent insider activity has consisted predominantly of sales rather than purchases. Why Is Intuitive Surgical Stock Trending After Hours?
Analyst Ratings Changes
A number of research firms have commented on ISRG. Royal Bank Of Canada reduced their target price on Intuitive Surgical from $650.00 to $600.00 and set an "outperform" rating on the stock in a research report on Monday, July 13th. Robert W. Baird reduced their price objective on shares of Intuitive Surgical from $525.00 to $500.00 and set an "outperform" rating on the stock in a report on Friday, July 17th. Raymond James Financial reaffirmed an "outperform" rating and issued a $483.00 target price (down from $577.00) on shares of Intuitive Surgical in a research report on Friday, July 17th. Citigroup lowered their target price on shares of Intuitive Surgical from $590.00 to $500.00 and set a "buy" rating for the company in a research note on Friday, July 17th. Finally, BMO Capital Markets reissued an "outperform" rating on shares of Intuitive Surgical in a research report on Monday, July 20th. Twenty-two investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $508.68.
Check Out Our Latest Stock Report on ISRG
About Intuitive Surgical
(
Get Free Report)
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
